A methylxanthine bronchodilator that inhibits phosphodiesterase activity and, thus, increases cAMP; demonstrates decreased affinity towards adenosine A1 and A2 receptors, does not interfere with calcium influx into cells, and does not antagonize the action of calcium-channel blockers.